BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 22912555)

  • 1. Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancer.
    Lim JY; Yoon SO; Seol SY; Hong SW; Kim JW; Choi SH; Cho JY
    World J Gastroenterol; 2012 Aug; 18(30):4037-43. PubMed ID: 22912555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome Analysis and the Prognostic Role of NUDC in Diffuse and Intestinal Gastric Cancer.
    Jeong SH; Park M; Park SY; Park J; Kim TH; Lee YJ; Jung EJ; Ju YT; Jeong CY; Kim JY; Ko GH; Kim M; Nam KT; Goldenring JR
    Technol Cancer Res Treat; 2021; 20():15330338211019501. PubMed ID: 34060350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target.
    Hur H; Xuan Y; Kim YB; Lee G; Shim W; Yun J; Ham IH; Han SU
    Int J Oncol; 2013 Jan; 42(1):44-54. PubMed ID: 23135628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological differences in signet ring cell adenocarcinoma between early and advanced gastric cancer.
    Kao YC; Fang WL; Wang RF; Li AF; Yang MH; Wu CW; Shyr YM; Huang KH
    Gastric Cancer; 2019 Mar; 22(2):255-263. PubMed ID: 30069742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of metabolic markers HK1 and PKM2 contributes to lymphatic metastasis and adverse prognosis in Chinese gastric cancer.
    Gao Y; Xu D; Yu G; Liang J
    Int J Clin Exp Pathol; 2015; 8(8):9264-71. PubMed ID: 26464675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer.
    Wang L; Li PF; Geng M; Cao YC; Yin YC
    Diagn Pathol; 2013 Feb; 8():33. PubMed ID: 23432846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia.
    Chon HJ; Hyung WJ; Kim C; Park S; Kim JH; Park CH; Ahn JB; Kim H; Chung HC; Rha SY; Noh SH; Jeung HC
    Ann Surg; 2017 May; 265(5):946-953. PubMed ID: 27232252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features and outcomes in patients undergoing radical resection for early gastric cancer with signet ring cell histology.
    Wang Z; Zhang X; Hu J; Zeng W; Zhou Z
    J Visc Surg; 2015 Dec; 152(6):357-61. PubMed ID: 26481069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyruvate kinase M2 contributes to cell growth in gastric cancer via aerobic glycolysis.
    Li H; Xu H; Xing R; Pan Y; Li W; Cui J; Lu Y
    Pathol Res Pract; 2019 Jun; 215(6):152409. PubMed ID: 31000383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential microRNA expression in signet-ring cell carcinoma compared with tubular adenocarcinoma of human gastric cancer.
    Li FQ; Xu B; Wu YJ; Yang ZL; Qian JJ
    Genet Mol Res; 2015 Jan; 14(1):739-47. PubMed ID: 25730011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
    Guo J; Zu G; Zhou T; Xing J; Wang Z
    Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of signet ring cell carcinoma of the stomach.
    Kim JP; Kim SC; Yang HK
    Surg Oncol; 1994 Aug; 3(4):221-7. PubMed ID: 7834113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathological features and prognostic analysis of patients with signet ring cell gastric carcinoma].
    Cui J; Liang H; Deng J; Ding X; Wang X; Zhang L; Liang Y; Jiang N
    Zhonghua Zhong Liu Za Zhi; 2015 May; 37(5):367-70. PubMed ID: 26463028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early gastric cancer of signet ring cell carcinoma is more amenable to endoscopic treatment than is early gastric cancer of poorly differentiated tubular adenocarcinoma in select tumor conditions.
    Kim HM; Pak KH; Chung MJ; Cho JH; Hyung WJ; Noh SH; Kim CB; Lee YC; Song SY; Lee SK
    Surg Endosc; 2011 Sep; 25(9):3087-93. PubMed ID: 21487870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of the GATA3 gene is associated with poor prognosis in primary gastric adenocarcinoma.
    Keshari RP; Wang W; Zhang Y; Wang DD; Li YF; Yuan SQ; Qiu HB; Huang CY; Chen YM; Xia JC; Zhou ZW
    PLoS One; 2014; 9(2):e87195. PubMed ID: 24504018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.
    Uchino S; Tsuda H; Maruyama K; Kinoshita T; Sasako M; Saito T; Kobayashi M; Hirohashi S
    Cancer; 1993 Dec; 72(11):3179-84. PubMed ID: 7902202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The percentages of signet-ring cells (SRCs) affects the prognosis after radical gastrectomy for advanced gastric cancer.
    Ma Y; Wang Y; Hu C; Zi M; Chen J; Cao M; Yuan L; Yang L; Du Y
    Langenbecks Arch Surg; 2023 Sep; 408(1):376. PubMed ID: 37743407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers.
    Desai S; Ding M; Wang B; Lu Z; Zhao Q; Shaw K; Yung WK; Weinstein JN; Tan M; Yao J
    Oncotarget; 2014 Sep; 5(18):8202-10. PubMed ID: 24077665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of cyclin-dependent kinase-activating CDC25B phosphatase in human gastric carcinomas.
    Kudo Y; Yasui W; Ue T; Yamamoto S; Yokozaki H; Nikai H; Tahara E
    Jpn J Cancer Res; 1997 Oct; 88(10):947-52. PubMed ID: 9414655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of the M2 isoform of pyruvate kinase is involved in gastric cancer development by regulating cancer-specific metabolism.
    Shiroki T; Yokoyama M; Tanuma N; Maejima R; Tamai K; Yamaguchi K; Oikawa T; Noguchi T; Miura K; Fujiya T; Shima H; Sato I; Murata-Kamiya N; Hatakeyama M; Iijima K; Shimosegawa T; Satoh K
    Cancer Sci; 2017 May; 108(5):931-940. PubMed ID: 28235245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.